Alembic Pharma rises after receiving USFDA nod for cancer drug

Alembic Pharmaceuticals rallied 3.74% to Rs 985.55 after the company announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Ivosidenib Tablets.